Wespac Advisors, LLC Bristol Myers Squibb CO Transaction History

Wespac Advisors, LLC

  • $168 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 27, 2020
SELL
$57.43 - $63.64 $1.52 Million - $1.68 Million
-26,391 Closed
0 $0
Q2 2020

Jul 22, 2020
SELL
$54.82 - $64.09 $81,407 - $95,173
-1,485 Reduced 5.33%
26,391 $1.55 Million
Q1 2020

Apr 22, 2020
SELL
$46.4 - $67.43 $117,624 - $170,935
-2,535 Reduced 8.34%
27,876 $1.55 Million
Q4 2019

Feb 07, 2020
BUY
$49.21 - $64.19 $1.5 Million - $1.95 Million
30,411 New
30,411 $1.95 Million

Others Institutions Holding BMY

# of Institutions
2,557
Shares Held
1.49B
Call Options Held
25.9M
Put Options Held
20M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $86.9B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wespac Advisors, LLC Portfolio

Follow Wespac Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wespac Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wespac Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email